Zhu Y, Hein D W
Department of Pharmacology and Toxicology and James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40292, USA.
Pharmacogenomics J. 2008 Oct;8(5):339-48. doi: 10.1038/sj.tpj.6500483. Epub 2007 Oct 2.
Genetic variants of human N-acetyltransferase 1 (NAT1) are associated with cancer and birth defects. N- and O-acetyltransferase catalytic activities, Michaelis-Menten kinetic constants (K(m) and V(max)) and steady-state expression levels of NAT1-specific mRNA and protein were determined for the reference NAT14 and variant human NAT1 haplotypes possessing single nucleotide polymorphisms (SNPs) in the open reading frame. Although none of the SNPs caused a significant effect on steady-state levels of NAT1-specific mRNA, C97T(R33stop), C190T(R64W), C559T (R187stop) and A752T(D251V) each reduced NAT1 protein level and/or N- and O-acetyltransferase catalytic activities to levels below detection. G560A(R187Q) substantially reduced NAT1 protein level and catalytic activities and increased substrate K(m). The G445A(V149I), G459A(synonymous) and T640G(S214A) haplotype present in NAT111 significantly (P<0.05) increased NAT1 protein level and catalytic activity. Neither T21G(synonymous), T402C(synonymous), A613G(M205V), T777C(synonymous), G781A(E261K) nor A787G(I263V) significantly affected K(m), catalytic activity, mRNA or protein level. These results suggest heterogeneity among slow NAT1 acetylator phenotypes.
人类N-乙酰基转移酶1(NAT1)的基因变异与癌症和出生缺陷有关。针对参考NAT14以及在开放阅读框中具有单核苷酸多态性(SNP)的变异人类NAT1单倍型,测定了N-和O-乙酰基转移酶的催化活性、米氏动力学常数(K(m)和V(max))以及NAT1特异性mRNA和蛋白质的稳态表达水平。尽管没有一个SNP对NAT1特异性mRNA的稳态水平产生显著影响,但C97T(R33stop)、C190T(R64W)、C559T(R187stop)和A752T(D251V)各自将NAT1蛋白质水平和/或N-和O-乙酰基转移酶催化活性降低至检测水平以下。G560A(R187Q)大幅降低了NAT1蛋白质水平和催化活性,并增加了底物K(m)。NAT111中存在的G445A(V149I)、G459A(同义突变)和T640G(S214A)单倍型显著(P<0.05)增加了NAT1蛋白质水平和催化活性。T21G(同义突变)、T402C(同义突变)、A613G(M205V)、T777C(同义突变)、G781A(E261K)和A787G(I263V)均未对K(m)、催化活性、mRNA或蛋白质水平产生显著影响。这些结果表明慢NAT1乙酰化酶表型之间存在异质性。